Rubin DT, Allegretti JR, Panes J, Shipitofsky N, et al. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies. Lancet 2024 Dec 17:S0140-6736(24)01927-5. doi: 10.1016/S0140-6736(24)01927.
PMID: 39706209